Latest & greatest articles for breast cancer

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on breast cancer or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on breast cancer and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for breast cancer

161. Sentinel lymph node dissection versus axillary systematic lymph node dissection in primary breast cancer: a systematic review and meta-analysis

Sentinel lymph node dissection versus axillary systematic lymph node dissection in primary breast cancer: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

162. Body image in older breast cancer survivors: a systematic review

Body image in older breast cancer survivors: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g

2019 PROSPERO

163. Barriers in the management of metastatic breast cancer patients

Barriers in the management of metastatic breast cancer patients Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g

2019 PROSPERO

164. Barriers and facilitators to participation in early detection strategies of breast cancer in migrant women: a systematic review

Barriers and facilitators to participation in early detection strategies of breast cancer in migrant women: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

165. A piggyback systematic review of the adverse effects of chemotherapy regimes in women with breast cancer

A piggyback systematic review of the adverse effects of chemotherapy regimes in women with breast cancer Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

166. Handheld ultrasound for breast cancer detection in low-resource settings: a systematic review and meta-analysis

Handheld ultrasound for breast cancer detection in low-resource settings: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

167. Feasibility of different treatments for sleep disturbance in peri-menopause and post-menopause breast cancer patients: a systematic review

Feasibility of different treatments for sleep disturbance in peri-menopause and post-menopause breast cancer patients: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

168. Human papillomavirus infection in breast cancer patients: a meta-analysis of case-control studies

Human papillomavirus infection in breast cancer patients: a meta-analysis of case-control studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

169. Evaluating the efficacy of bone modifying agents (BMAs) for treating bone metastasis originating from breast cancer: an updated systemic review and network meta-analysis including RCT data from China

Evaluating the efficacy of bone modifying agents (BMAs) for treating bone metastasis originating from breast cancer: an updated systemic review and network meta-analysis including RCT data from China Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

170. Methyl-group donors and the risk of breast cancer: a systematic review and meta-analysis

Methyl-group donors and the risk of breast cancer: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

171. A meta-analysis on diagnostic accuracy of serum HLA-G level for breast cancer

A meta-analysis on diagnostic accuracy of serum HLA-G level for breast cancer Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

172. Association between obesity-related biomarkers and breast cancer risk: a systematic review and dose-response meta-analysis

Association between obesity-related biomarkers and breast cancer risk: a systematic review and dose-response meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

173. Adherence to adjuvant endocrine therapy in patients with breast cancer: a systematic review of qualitative research

Adherence to adjuvant endocrine therapy in patients with breast cancer: a systematic review of qualitative research Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

174. A systematic review of the adoption of the Choosing Wisely guidelines in breast cancer surgery to reduce overutilization

A systematic review of the adoption of the Choosing Wisely guidelines in breast cancer surgery to reduce overutilization Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

175. Does aquatic therapy reduce pain and fatigue among people with breast cancer? A systematic review

Does aquatic therapy reduce pain and fatigue among people with breast cancer? A systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

176. Comparative effectiveness of tamoxifene, toremifene, letrozole, anastrozole and exemestane on lipid profiles in breast cancer patients: A network meta-analysis.

Comparative effectiveness of tamoxifene, toremifene, letrozole, anastrozole and exemestane on lipid profiles in breast cancer patients: A network meta-analysis. Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

177. Optimal duration of adjuvant trastuzumab in treatment of early human epidermal growth factor receptor-2 (HER2) positive breast cancer: protocol for a network meta-analysis of randomized trials

Optimal duration of adjuvant trastuzumab in treatment of early human epidermal growth factor receptor-2 (HER2) positive breast cancer: protocol for a network meta-analysis of randomized trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

178. Physical activity and exercise related effects in patients with metastatic breast cancer: a systematic review

Physical activity and exercise related effects in patients with metastatic breast cancer: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

179. A systematic review and meta-analysis of eHealth technology interventions for endocrine therapy patients with breast cancer

A systematic review and meta-analysis of eHealth technology interventions for endocrine therapy patients with breast cancer Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

180. 18F-FDG PET/CT in the staging of inflammatory breast cancer: a systematic review

18F-FDG PET/CT in the staging of inflammatory breast cancer: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO